ArticleCurrent oncology (Toronto, Ont.)2009

The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer.

S Dent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.